Combining temozolomide with other antitumor drugs and target-based agents in the treatment of brain metastases: an unending quest or chasing a chimera?

Author： Addeo Raffaele   Caraglia Michele  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.7, 2011-07, pp. : 881-895

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temozolomide for brain metastases?

By  

Inpharma, Vol. 1, Iss. 1446, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 479-485

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: [Hot Topic: New Approaches in the Treatment of Multiple Myeloma: From Target-based Agents to the New Era of microRNAs (Dedicated to the Memory of Prof. Salvatore Venuta)]

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-01 ,pp. : 741-742

Bentham Science Publishers

Access to resources Recommend Favorite

The brain as a target for development of new class of drugs for the treatment of somatic diseases

By Mravec Boris  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 433-437

Informa Healthcare

Access to resources Recommend Favorite

Carbohydrate-Based Drugs in the Treatment of Epilepsy, Depression and Other Affective Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 2, 2008-01 ,pp. : 159-170

Bentham Science Publishers

Access to resources Recommend Favorite